Inhibrx Biosciences, Inc. Liquidation Value
INBX
Other
Cash & Equivalents
$124.22M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $124.22M
Total Obligations: -$140.81M
$-16.59M
Per share: $-1.14
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $124.22M
AR: $177,000
Total Obligations: -$140.81M
$-16.41M
Per share: $-1.13
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $124.22M
AR: $177,000
Inventory: $0
Total Obligations: -$140.81M
$-16.41M
Per share: $-1.13
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-16.59M | $-1.14 |
| Liquid Liquidation Value | $-16.41M | $-1.13 |
| Operating Liquidation Value | $-16.41M | $-1.13 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $124.22M |
| Accounts Receivable | $177,000 |
| Inventory | N/A |
| Current Liabilities | $33.80M |
| Long-term Debt | $100.56M |
| Op. Lease Liability | $6.45M |
| Finance Lease | N/A |
| Shares Outstanding | 14.6M |
Explore all 123 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $124.22M | $177,000 | N/A | $5.94M | $33.80M | $100.56M | $6.45M | N/A |
| 2025-09-30 | $153.09M | $727,000 | N/A | $6.77M | $35.98M | $99.92M | $6.99M | N/A |
| 2025-06-30 | $186.57M | $730,000 | N/A | $8.29M | $38.94M | $99.28M | $7.51M | N/A |
| 2025-03-31 | $216.52M | N/A | N/A | $8.89M | $43.64M | $98.65M | $7.88M | N/A |
| 2024-12-31 | $152.60M | $197,000 | N/A | $9.24M | $40.73M | $0 | $8.05M | N/A |
| 2024-09-30 | $196.33M | N/A | N/A | $12.37M | $44.09M | $0 | $1.83M | N/A |
| 2024-06-30 | $226.86M | $952,000 | N/A | $13.02M | $39.05M | $0 | $2.17M | N/A |
| 2024-03-31 | $252.48M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes